These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30556732)

  • 1. Does antagonism at 5-HT2A receptors potentiate D₂ blockade-induced disruption of conditioned avoidance response?
    Gao J; Huang Y; Li M
    Exp Clin Psychopharmacol; 2019 Apr; 27(2):103-108. PubMed ID: 30556732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of serotonin 5-HT
    Nie L; Di T; Li Y; Cheng P; Li M; Gao J
    Pharmacol Biochem Behav; 2018 Aug; 171():74-84. PubMed ID: 29944910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT
    Gao J; Chen L; Li M
    Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG; Browning JL; Young KA; Hicks PB
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M; Sun T; Zhang C; Hu G
    Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
    Feng M; Sparkman NL; Sui N; Li M
    J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.
    Wadenberg ML; Hicks PB; Richter JT; Young KA
    Biol Psychiatry; 1998 Sep; 44(6):508-15. PubMed ID: 9777184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.
    Zhang C; Li M
    Behav Pharmacol; 2012 Feb; 23(1):66-79. PubMed ID: 22157143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats.
    Jacobson SM; Prus AJ
    Behav Pharmacol; 2010 Oct; 21(7):654-9. PubMed ID: 20729715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.
    Gao J; Li M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():67-75. PubMed ID: 24942467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
    Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
    Kehne JH; Baron BM; Carr AA; Chaney SF; Elands J; Feldman DJ; Frank RA; van Giersbergen PL; McCloskey TC; Johnson MP; McCarty DR; Poirot M; Senyah Y; Siegel BW; Widmaier C
    J Pharmacol Exp Ther; 1996 May; 277(2):968-81. PubMed ID: 8627580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
    Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range.
    Baba S; Enomoto T; Horisawa T; Hashimoto T; Ono M
    J Pharmacol Sci; 2015 Mar; 127(3):326-31. PubMed ID: 25837930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
    Benaliouad F; Kapur S; Rompré PP
    Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.
    Creed-Carson M; Oraha A; Nobrega JN
    Behav Brain Res; 2011 Jun; 219(2):273-9. PubMed ID: 21262266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
    Gao J; Qin R; Li M
    J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.
    Chen W; Zhang Q; Su W; Zhang H; Yang Y; Qiao J; Sui N; Li M
    Pharmacol Biochem Behav; 2014 Feb; 117():25-33. PubMed ID: 24321440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia.
    Sparkman NL; Li M
    Behav Pharmacol; 2012 Oct; 23(7):658-68. PubMed ID: 22903071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.